𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Survival benefit associated with human anti-mouse antibody (HAMA) in patients with B-cell malignancies

✍ Scribed by Ignacio Azinovic; Gerald L. DeNardo; Kathleen R. Lamborn; Gary Mirick; Desiree Goldstein; Bonnie M. Bradt; Sally J. DeNardo


Publisher
Springer-Verlag
Year
2006
Tongue
English
Weight
264 KB
Volume
55
Category
Article
ISSN
0340-7004

No coin nor oath required. For personal study only.


📜 SIMILAR VOLUMES


Generation of human B-cell hybridomas se
✍ Dr. Linda Spatz; Becky Lieberson; Judith Abraham; Orlando J. Miller; Dorothy A. 📂 Article 📅 1987 🏛 John Wiley and Sons 🌐 English ⚖ 797 KB

This heterogeneity showed that all components of the infarcted area were not equally damaged. These isointensity transverse bands were probably the spared nerve fiber bundles projecting into the cerebellar hemisphere from the contralateral pontine nuclei. In the cerebral hemispheres, the region mos

Level of anti-mouse-antibody response in
✍ Silvia Miotti; Donatella R.M. Negri; Olga Valota; Marcella Calabrese; Reinder L. 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 French ⚖ 88 KB

More than 60% of cancer patients injected with intact murine monoclonal antibody (MAb) develop a humoral response against the antigen even after a single dose. Analysis of a series of 35 ovarian-cancer patients entered in phase-I and -II clinical studies of T-cells retargeted with the bi-specific F(

Long-term survival in patients with huma
✍ Alan B. Astrow; Grace Tarabay; Vincent E. Salerno; William A. Cook; Robert Lin; 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 117 KB

## Abstract While intensive chemotherapy is recommended for the treatment of non‐HIV related adult small non‐cleaved lymphoma (SNCL), including Burkitt's and Burkitt‐like lymphoma, optimal treatment for patients with HIV‐associated SNCL is not known. We assessed remissions and survival in a cohort